{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:52:31Z","timestamp":1789815151764,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T00:00:00Z","timestamp":1395100800000},"content-version":"vor","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1CA149655"],"award-info":[{"award-number":["RO1CA149655"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1CA105129"],"award-info":[{"award-number":["RO1CA105129"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1GM088847"],"award-info":[{"award-number":["RO1GM088847"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1CA133379"],"award-info":[{"award-number":["RO1CA133379"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1RO1CA173636"],"award-info":[{"award-number":["1RO1CA173636"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32HL007151-33"],"award-info":[{"award-number":["5T32HL007151-33"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1T32CA160002-01"],"award-info":[{"award-number":["1T32CA160002-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002012","name":"Chemotherapy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012647","name":"William Lawrence and Blanche Hughes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ccr.2013.01.025","type":"journal-article","created":{"date-parts":[[2013,3,18]],"date-time":"2013-03-18T12:06:09Z","timestamp":1363608369000},"page":"362-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Regulation of c-Myc Ubiquitination Controls Chronic Myelogenous Leukemia Initiation and Progression"],"prefix":"10.1016","volume":"23","author":[{"given":"Linsey","family":"Reavie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon\u00a0M.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Loizou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichiro","family":"Takeishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Aranda-Orgilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Ndiaye-Lobry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi\u00a0I.","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iannis","family":"Aifantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2013.01.025_bib1","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nbt.1645","article-title":"Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase","volume":"28","author":"Aghajan","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccr.2013.01.025_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/306277a0","article-title":"Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia","volume":"306","author":"Bartram","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.025_bib3","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment","volume":"101","author":"Bhatia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2013.01.025_bib4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccr.2013.01.025_bib5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccr.2009.08.015","article-title":"Functional identification of tumor-suppressor genes through an in\u00a0vivo RNA interference screen in a mouse lymphoma model","volume":"16","author":"Bric","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2013.01.025_bib6","first-page":"5685","article-title":"Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl","volume":"9","author":"Cleveland","year":"1989","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ccr.2013.01.025_bib7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccr.2013.01.025_bib8","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ccr.2013.01.025_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1074-7613(01)00088-7","article-title":"Analysis of C-MYC function in normal cells via conditional gene-targeted mutation","volume":"14","author":"de Alboran","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.ccr.2013.01.025_bib10","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1200\/JCO.2007.15.8154","article-title":"Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis","volume":"26","author":"de Lavallade","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccr.2013.01.025_bib11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2013.01.025_bib12","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccr.2013.01.025_bib13","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ccr.2013.01.025_bib14","doi-asserted-by":"crossref","first-page":"51606","DOI":"10.1074\/jbc.M310722200","article-title":"Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization","volume":"278","author":"Gregory","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccr.2013.01.025_bib15","doi-asserted-by":"crossref","first-page":"34371","DOI":"10.1074\/jbc.M101343200","article-title":"Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor","volume":"276","author":"Gupta-Rossi","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccr.2013.01.025_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.stem.2012.02.017","article-title":"Genetic and pharmacologic inhibition of \u03b2-catenin targets imatinib-resistant leukemia stem cells in CML","volume":"10","author":"Heidel","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ccr.2013.01.025_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/344251a0","article-title":"Acute leukaemia in bcr\/abl transgenic mice","volume":"344","author":"Heisterkamp","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.025_bib18","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/leu.2009.38","article-title":"Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia","volume":"23","author":"Hochhaus","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.ccr.2013.01.025_bib19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/eji.200737972","article-title":"Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse","volume":"38","author":"Huang","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ccr.2013.01.025_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrc1592","article-title":"Leukaemia stem cells and the evolution of cancer-stem-cell research","volume":"5","author":"Huntly","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccr.2013.01.025_bib21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nature09171","article-title":"Regulation of myeloid leukaemia by the cell-fate determinant Musashi","volume":"466","author":"Ito","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.025_bib22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccr.2013.01.025_bib23","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1182\/blood-2009-02-205690","article-title":"Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic\/myeloproliferative neoplasms","volume":"113","author":"Jankowska","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2013.01.025_bib24","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1182\/blood.V74.7.2318.2318","article-title":"Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia","volume":"74","author":"Kelman","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2013.01.025_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1126\/science.1065203","article-title":"Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase","volume":"294","author":"Koepp","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ccr.2013.01.025_bib26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.025_bib27","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1182\/blood.V95.5.1758.005a41_1758_1766","article-title":"Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification","volume":"95","author":"le Coutre","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2013.01.025_bib28","doi-asserted-by":"crossref","first-page":"280502","DOI":"10.4061\/2011\/280502","article-title":"Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer\u2019s disease treatment","volume":"2011","author":"Martinez","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.ccr.2013.01.025_bib29","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1101\/gad.1621808","article-title":"Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL","volume":"22","author":"Matsuoka","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2013.01.025_bib30","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nature03669","article-title":"Dynamics of chronic myeloid leukaemia","volume":"435","author":"Michor","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.025_bib31","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/ijc.26065","article-title":"Down-regulation of Thanatos-associated protein 11 by BCR-ABL promotes CML cell proliferation through c-Myc expression","volume":"130","author":"Nakamura","year":"2012","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.ccr.2013.01.025_bib32","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2007-02-073031","article-title":"Leukemia stem cells in a genetically defined murine model of blast-crisis CML","volume":"110","author":"Neering","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2013.01.025_bib33","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell","year":"1960","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ccr.2013.01.025_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.gde.2005.11.002","article-title":"Targeted CML therapy: controlling drug resistance, seeking cure","volume":"16","author":"O\u2019Hare","year":"2006","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.ccr.2013.01.025_bib35","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.20070876","article-title":"FBW7 mutations in\u00a0leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors","volume":"204","author":"O\u2019Neil","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccr.2013.01.025_bib36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nbt.1646","article-title":"An allosteric inhibitor of substrate recognition by the SCF(Cdc4) ubiquitin ligase","volume":"28","author":"Orlicky","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccr.2013.01.025_bib37","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","article-title":"Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow","volume":"92","author":"Pear","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2013.01.025_bib38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ni.1839","article-title":"Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-substrate complex","volume":"11","author":"Reavie","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccr.2013.01.025_bib39","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ccr.2011.10.012","article-title":"IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development","volume":"20","author":"Reynaud","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2013.01.025_bib40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.025_bib41","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0092-8674(92)90241-4","article-title":"Dominant negative MYC blocks transformation by ABL oncogenes","volume":"70","author":"Sawyers","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2013.01.025_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","article-title":"Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia","volume":"2","author":"Shah","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2013.01.025_bib43","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood.V87.4.1539.bloodjournal8741539","article-title":"Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis","volume":"87","author":"Sirard","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2013.01.025_bib44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1242\/dev.01558","article-title":"Assessing the role of hematopoietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing","volume":"132","author":"Stadtfeld","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.ccr.2013.01.025_bib45","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccr.2013.01.026","article-title":"Ablation of Fbw7 eliminates leukemia-intiating cells by preventing quiescence","volume":"23","author":"Takeishi","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2013.01.025_bib46","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1084\/jem.20070872","article-title":"The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T\u00a0cell leukemia","volume":"204","author":"Thompson","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccr.2013.01.025_bib47","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.20080277","article-title":"Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7","volume":"205","author":"Thompson","year":"2008","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccr.2013.01.025_bib48","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1182\/blood.V91.7.2406","article-title":"High level engraftment of NOD\/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase","volume":"91","author":"Wang","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2013.01.025_bib49","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nature07284","article-title":"Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy","volume":"455","author":"Wang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.01.025_bib50","doi-asserted-by":"crossref","first-page":"9085","DOI":"10.1073\/pnas.0402770101","article-title":"The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation","volume":"101","author":"Welcker","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2013.01.025_bib51","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1073\/pnas.0602402103","article-title":"Loss of p53 impedes the antileukemic response to BCR-ABL inhibition","volume":"103","author":"Wendel","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2013.01.025_bib52","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1182\/blood.V99.11.4122","article-title":"BCR-ABL-induced adhesion defects are tyrosine kinase-independent","volume":"99","author":"Wertheim","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2013.01.025_bib53","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1038\/sj.onc.1205942","article-title":"Jak2 is involved in c-Myc induction by Bcr-Abl","volume":"21","author":"Xie","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2013.01.025_bib54","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/sj.emboj.7600217","article-title":"Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7","volume":"23","author":"Yada","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.ccr.2013.01.025_bib55","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","article-title":"Loss of beta-catenin impairs the renewal of normal and CML stem cells in\u00a0vivo","volume":"12","author":"Zhao","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2013.01.025_bib56","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07737","article-title":"Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia","volume":"458","author":"Zhao","year":"2009","journal-title":"Nature"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610813000445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610813000445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:22:11Z","timestamp":1778617331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610813000445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1535610813000445"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2013.01.025","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of c-Myc Ubiquitination Controls Chronic Myelogenous Leukemia Initiation and Progression","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccr.2013.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ccr.2013.01.026","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}